These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15162897)

  • 1. Food: an unrecognized source of loop diuretic resistance.
    Bard RL; Bleske BE; Nicklas JM
    Pharmacotherapy; 2004 May; 24(5):630-7. PubMed ID: 15162897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsemide: a pyridine-sulfonylurea loop diuretic.
    Blose JS; Adams KF; Patterson JH
    Ann Pharmacother; 1995 Apr; 29(4):396-402. PubMed ID: 7633019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure.
    Gottlieb SS; Khatta M; Wentworth D; Roffman D; Fisher ML; Kramer WG
    Am J Med; 1998 Jun; 104(6):533-8. PubMed ID: 9674715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
    Vargo DL; Kramer WG; Black PK; Smith WB; Serpas T; Brater DC
    Clin Pharmacol Ther; 1995 Jun; 57(6):601-9. PubMed ID: 7781259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacodynamics of intravenous and oral torsemide in patients with chronic renal insufficiency.
    Rudy DW; Gehr TW; Matzke GR; Kramer WG; Sica DA; Brater DC
    Clin Pharmacol Ther; 1994 Jul; 56(1):39-47. PubMed ID: 8033493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of the loop diuretics furosemide and torasemide on diuresis in dogs and cats.
    Uechi M; Matsuoka M; Kuwajima E; Kaneko T; Yamashita K; Fukushima U; Ishikawa Y
    J Vet Med Sci; 2003 Oct; 65(10):1057-61. PubMed ID: 14600341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy in congestive heart failure: drug absorption in the management of congestive heart failure: loop diuretics.
    Sica DA
    Congest Heart Fail; 2003; 9(5):287-92. PubMed ID: 14564148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of loop diuretics.
    Brater DC
    Drugs; 1991; 41 Suppl 3():14-22. PubMed ID: 1712712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in the renal sodium transporters NKCC2, NCC, and ENaC in relation to the effects of loop diuretic drugs.
    Vormfelde SV; Sehrt D; Toliat MR; Schirmer M; Meineke I; Tzvetkov M; Nürnberg P; Brockmöller J
    Clin Pharmacol Ther; 2007 Sep; 82(3):300-9. PubMed ID: 17460608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal actions of piretanide and three other "loop" diuretics.
    McNabb WR; Noormohamed FH; Brooks BA; Lant AF
    Clin Pharmacol Ther; 1984 Mar; 35(3):328-37. PubMed ID: 6697640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of intravenous bumetanide in mutant Nagase analbuminemic rats: importance of globulin binding for the pharmacodynamic effects.
    Kim EJ; Lee MG
    Biopharm Drug Dispos; 2001 May; 22(4):147-56. PubMed ID: 11745917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
    Kido H; Ohtaki Y
    Nihon Yakurigaku Zasshi; 2001 Aug; 118(2):97-105. PubMed ID: 11530685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torasemide for the treatment of heart failure.
    Ishido H; Senzaki H
    Cardiovasc Hematol Disord Drug Targets; 2008 Jun; 8(2):127-32. PubMed ID: 18537599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic properties of orally administered torsemide in healthy horses.
    Agne GF; Jung SW; Wooldridge AA; Duran SH; Ravis W; Toribio R
    J Vet Intern Med; 2018 Jul; 32(4):1428-1435. PubMed ID: 29770976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of loop diuretics in patients with chronic renal insufficiency.
    Voelker JR; Cartwright-Brown D; Anderson S; Leinfelder J; Sica DA; Kokko JP; Brater DC
    Kidney Int; 1987 Oct; 32(4):572-8. PubMed ID: 3430953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal excretory profiles of loop diuretics: consequences for therapeutic application.
    Reyes AJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 3():S11-23. PubMed ID: 7506333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral administration of furosemide and torsemide in healthy dogs.
    Hori Y; Takusagawa F; Ikadai H; Uechi M; Hoshi F; Higuchi S
    Am J Vet Res; 2007 Oct; 68(10):1058-63. PubMed ID: 17916010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology of torasemide, a new loop diuretic.
    Brater DC; Leinfelder J; Anderson SA
    Clin Pharmacol Ther; 1987 Aug; 42(2):187-92. PubMed ID: 3608350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2C9 polymorphisms and the interindividual variability in pharmacokinetics and pharmacodynamics of the loop diuretic drug torsemide.
    Vormfelde SV; Engelhardt S; Zirk A; Meineke I; Tuchen F; Kirchheiner J; Brockmöller J
    Clin Pharmacol Ther; 2004 Dec; 76(6):557-66. PubMed ID: 15592327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive review of the loop diuretics: should furosemide be first line?
    Wargo KA; Banta WM
    Ann Pharmacother; 2009 Nov; 43(11):1836-47. PubMed ID: 19843838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.